Montara targets Parkinson’s with brain-only drug approach

New funding from The Michael J Fox Foundation backs a strategy that could unlock a long-studied pathway linked to both Parkinson’s and aging. Scientists have long been intrigued by a biological pathway called mTOR. It sits at the center of some of the most exciting research in aging, helping regulate how cells grow, repair themselves […] The post Montara targets Parkinson’s with brain-only drug approach appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.